Healthcare Press

Bristol-Myers beefs up cancer portfolio with US$74 billion Celgene buy

  • 📰 ChannelNewsAsia
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 66%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

Cancer drugmaker Bristol-Myers Squibb Co said on Thursday it would buy Celgene Corp for about US$74 billion in a cash-and-stock deal.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 6. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Bristol-Myers to buy Celgene for US$74 billionCancer drugmaker Bristol-Myers Squibb Co said on Thursday it would buy Celgene Corp for about US$74 billion in a cash-and-stock deal.
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Bristol-Myers to buy Celgene for US$74 billion in largest biopharma dealCancer drugmaker Bristol-Myers Squibb Co said on Thursday it would buy Celgene Corp for about US$74 billion in a cash-and-stock deal.
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »